MedTrace Logo

Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement

NCT06146504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-22

No results posted yet for this study

Summary

This is a virtual, double-blind, two-arm, randomized, placebo-controlled clinical trial that will last 12 weeks. Participants will take the CanXida Remove Candida Cleansing Formula RMV or a placebo product daily and complete questionnaires at Baseline, Week 6, and Week 12. Candida microbiome testing will be conducted via stool sample at Baseline and Week 12.

The participants will all be blinded to the name of the test brand.

Conditions

  • Candida Systemic
  • Candida Albicans Infection
  • Candida Infection

Interventions

DIETARY_SUPPLEMENT

CanXida Remove (Formula RMV)

Supplement composed of a 12 ingredient anti-fungal, anti-bacterial \& anti-parasite formula.

OTHER

Placebo

Placebo product containing Dicalcium Phosphate, Magnesium Stearate, Stearic Acid, Croscarmellose Sodium, and Silica.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • CanXida

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-06-28
Completion
2024-06-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06146504 on ClinicalTrials.gov